G. Steven Burrill

An introduction to Burrill Venture Capital

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

News

Biotech takes a beating in market meltdown October 01, 2008 | Press Release

Biotech outperforms market in May June 02, 2008 | Press Release

Biotech Treads Water in April May 01, 2008 | Press Release

  See all News
Sign up to receive email notifications about our upcoming events and news.


Submit a Business Plan

Do great things with us.Click here 
Venture Capital

 


Neosil is a privately-held dermatology-focused specialty pharmaceutical company with several products in pre-clinical development. The company's core topical anti-infective technology provides broad anti-microbial activity, long duration of activity and excellent formulation flexibility.

For more information, please visit


Website: http://www.neosil.com